SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
21572789
Source:
http://linkedlifedata.com/resource/pubmed/id/21572789
Search
Subject
(
36
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0004623
,
umls-concept:C0023283
,
umls-concept:C0061366
,
umls-concept:C0175668
,
umls-concept:C0205216
,
umls-concept:C0231242
,
umls-concept:C1280500
pubmed:issue
1
pubmed:dateCreated
2011-5-16
pubmed:abstractText
Glucantime is regarded as the first-line treatment of cutaneous leishmaniasis (CL); however, failure to treatment is a problem in many cases.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/21572789-12609780
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21572789-1304703
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21572789-16418526
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21572789-16605301
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21572789-18830062
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21572789-2208560
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0370750
pubmed:status
PubMed-not-MEDLINE
pubmed:month
Jan
pubmed:issn
1998-3611
pubmed:author
pubmed-author:BaghbaderaniA ZolfaghariAZ
,
pubmed-author:BidabadiL ShiraniLS
,
pubmed-author:SadeghianGG
,
pubmed-author:ZiaeiHH
pubmed:issnType
Electronic
pubmed:volume
56
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
37-9
pubmed:dateRevised
2011-7-28
pubmed:year
2011
pubmed:articleTitle
Decreased effect of glucantime in cutaneous leishmaniasis complicated with secondary bacterial infection.
pubmed:affiliation
Skin Disease and Leishmaniasis Research Center, Isfahan, Iran.
pubmed:publicationType
Journal Article